Delcath Systems, Inc. (DCTH)
Largest Insider Buys in Sector
DCTH Stock Price History Chart
DCTH Stock Performance
About Delcath Systems, Inc.
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.
Insider Activity of Delcath Systems, Inc.
Over the last 12 months, insiders at Delcath Systems, Inc. have bought $200,002 and sold $0 worth of Delcath Systems, Inc. stock.
On average, over the past 5 years, insiders at Delcath Systems, Inc. have bought $620,737 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Aharon Gil (director) — $100,001. SALAMON STEVEN A J (director) — $100,001.
The last purchase of 26,882 shares for transaction amount of $100,001 was made by SALAMON STEVEN A J (director) on 2024‑03‑19.
List of Insider Buy and Sell Transactions, Delcath Systems, Inc.
| 2024-03-19 | director | 26,882 0.106% | $3.72 | $100,001 | +92.29% | |||
| 2024-03-19 | director | 26,882 0.106% | $3.72 | $100,001 | +92.29% | |||
| 2023-12-12 | Chief Medical Officer | 40,000 0.1728% | $3.00 | $120,000 | +116.59% | |||
| 2023-12-08 | Chief Executive Officer | 34,000 0.1516% | $2.94 | $99,960 | +125.36% | |||
| 2023-11-17 | director | 100,000 0.6437% | $2.40 | $240,410 | +122.22% | |||
| 2023-11-17 | SVP of Finance, PFO and PAO | 30,000 0.1952% | $2.43 | $72,900 | +122.22% | |||
| 2023-11-16 | Chief Medical Officer | 60,000 0.3928% | $2.48 | $148,800 | +118.42% | |||
| 2023-11-16 | See Remarks | 40,000 0.2618% | $2.48 | $99,200 | +118.42% | |||
| 2023-10-13 | Chief Operating Officer | 14,505 0.0944% | $3.44 | $49,897 | +36.99% | |||
| 2023-08-21 | director | 10,550 0.093% | $4.80 | $50,640 | -11.42% | |||
| 2023-03-29 | Chief Executive Officer | 19,646 0.0001% | $4.84 | $95,087 | -19.95% | |||
| 2022-12-14 | director | 15,215 0.1678% | $3.62 | $55,045 | +26.22% | |||
| 2022-12-14 | director | 15,215 0.1678% | $3.62 | $55,045 | +26.22% | |||
| 2022-12-13 | Chief Executive Officer | 51,725 0.4573% | $2.90 | $150,003 | +26.22% | |||
| 2022-07-20 | Chief Executive Officer | 62,814 0.6782% | $3.98 | $250,000 | +7.50% | |||
| 2022-05-16 | Chief Operating Officer | 3,300 0.0396% | $4.61 | $15,213 | -13.01% | |||
| 2022-05-13 | 5,000 0.0635% | $5.03 | $25,135 | -15.89% | ||||
| 2022-05-12 | 6,000 0.0764% | $4.90 | $29,424 | -13.19% | ||||
| 2022-04-19 | 1,600 0.0191% | $6.25 | $10,000 | -36.05% | ||||
| 2022-04-19 | 1,600 0.0191% | $6.25 | $10,000 | -36.05% |
Insider Historical Profitability
| SALAMON STEVEN A J | director | 1121025 3.5061% | $13.61 | 14 | 0 | <0.0001% |
| Aharon Gil | director | 1069710 3.3456% | $13.61 | 3 | 0 | <0.0001% |
| Rosalind Advisors, Inc. | director | 1038828 3.249% | $13.61 | 12 | 0 | <0.0001% |
| LADD ROBERT | director | 631294 1.9744% | $13.61 | 48 | 11 | |
| MICHEL GERARD J | Chief Executive Officer | 262345 0.8205% | $13.61 | 11 | 0 | <0.0001% |
| Taglietti Marco | director | 220000 0.6881% | $13.61 | 2 | 0 | |
| Philips Laura A | director | 205299 0.6421% | $13.61 | 8 | 0 | |
| HOBBS EAMONN P | President and CEO | 162000 0.5067% | $13.61 | 2 | 0 | |
| Taney Richard | Chief Executive Officer | 161000 0.5035% | $13.61 | 5 | 0 | |
| HERSCHKOWITZ SAMUEL /FA/ | Chief Operating Officer | 160375 0.5016% | $13.61 | 2 | 10 | |
| Kandarpa Krishna | Exec. V.P., Chief Medical Off. | 150000 0.4691% | $13.61 | 0 | 1 | |
| Koplewicz Harold S | director | 148521 0.4645% | $13.61 | 5 | 0 | |
| CORIGLIANO MARK | director | 141225 0.4417% | $13.61 | 0 | 1 | |
| Vukovic Vojo | Chief Medical Officer | 100000 0.3128% | $13.61 | 2 | 0 | |
| WATSON DOUGLAS G | director | 61369 0.1919% | $13.61 | 1 | 0 | |
| Miao Graham G | Exec. V.P., CFO | 54000 0.1689% | $13.61 | 1 | 0 | |
| Purpura John | Chief Operating Officer | 41526 0.1299% | $13.61 | 7 | 0 | <0.0001% |
| Hoffman David L. | See Remarks | 40000 0.1251% | $13.61 | 1 | 0 | |
| Pennell Sandra | SVP of Finance, PFO and PAO | 30000 0.0938% | $13.61 | 1 | 0 | |
| LEUNG GABRIEL | director | 15847 0.0496% | $13.61 | 1 | 0 | |
| Sylvester John Richard | director | 10550 0.033% | $13.61 | 1 | 0 | |
| Rueckert William Dodge | director | 7926 0.0248% | $13.61 | 3 | 0 | |
| Keck Barbra | Chief Financial Officer | 7500 0.0235% | $13.61 | 3 | 0 | |
| Simpson Jennifer K. | President & CEO | 7500 0.0235% | $13.61 | 3 | 0 | |
| STOLL ROGER G PHD | director | 5901 0.0185% | $13.61 | 5 | 0 | |
| KOLY M S /FA/ | President and CEO | 0 0% | $13.61 | 0 | 2 |
Institutional Investor Ownership
| Aigh Capital Management Llc | $11.09M | 8.49 | 2.36M | +99.61% | +$5.54M | 6.34 | |
| Vivo Capital | $7.95M | 6 | 1.67M | +94.9% | +$3.87M | 0.69 | |
| Bvf Inc Il | $5.73M | 4.33 | 1.2M | +23.14% | +$1.08M | 0.04 | |
| The Vanguard Group | $3.26M | 2.46 | 683,686 | +30.97% | +$771,204.01 | <0.0001 | |
| CIBC World Markets | $1.24M | 0.94 | 260,280 | -0.44% | -$5,482.78 | <0.01 | |
| Geode Capital Management | $1.06M | 0.8 | 223,005 | +31.49% | +$254,777.61 | <0.0001 | |
| Hunting Hill Global Capital Llc | $497,978.00 | 0.38 | 104,398 | -36.67% | -$288,336.69 | 0.32 | |
| Morgan Stanley | $452,167.00 | 0.34 | 94,794 | +14.22% | +$56,285.95 | <0.0001 | |
| BlackRock | $434,423.00 | 0.33 | 91,074 | -0.93% | -$4,092.66 | <0.0001 | |
| Marshall Wace | $413,392.00 | 0.31 | 86,665 | -33.55% | -$208,735.17 | <0.0001 | |
| State Street | $327,971.00 | 0.25 | 68,757 | 0% | +$0 | <0.0001 | |
| Northern Trust | $300,977.00 | 0.23 | 63,098 | +4.01% | +$11,595.85 | <0.0001 | |
| Levin Capital Strategies | $262,202.00 | 0.2 | 54,969 | +12.18% | +$28,472.12 | 0.03 | |
| Citadel Advisors LLC | $204,676.00 | 0.15 | 42,909 | -24.96% | -$68,096.54 | <0.0001 | |
| Millennium Management LLC | $175,183.00 | 0.13 | 36,726 | +21.39% | +$30,866.67 | <0.0001 | |
| Jane Street Capital | $111,762.00 | 0.08 | 23,430 | New | +$111,762.00 | <0.0001 | |
| Wealthplan Investment Management Llc | $83,203.00 | 0.06 | 17,443 | 0% | +$0 | 0.01 | |
| Wolverine Trading | $63,932.00 | 0.05 | 13,403 | -31.87% | -$29,907.76 | <0.01 | |
| Two Sigma | $61,814.00 | 0.05 | 12,959 | -40.32% | -$41,756.29 | <0.0001 | |
| Engineers Gate Manager Lp | $53,863.00 | 0.04 | 11,292 | New | +$53,863.00 | <0.01 | |
| Simplex Trading Llc | $52,000.00 | 0.04 | 10,937 | -20.83% | -$13,678.70 | <0.01 | |
| Tower Research Capital | $33,314.00 | 0.03 | 6,984 | +132.57% | +$18,989.55 | <0.0001 | |
| Royal Bank of Canada | $17,000.00 | 0.01 | 3,500 | +5,203.03% | +$16,679.43 | <0.0001 | |
| Investors Research Corp | $13,833.00 | 0.01 | 2,900 | -25.64% | -$4,770.00 | <0.01 | |
| Wells Fargo | $13,714.00 | 0.01 | 2,875 | +1.91% | +$257.58 | <0.0001 | |
| UBS | $3,807.00 | <0.01 | 798 | +26,500% | +$3,792.69 | <0.0001 | |
| Quent Capital | $2,476.00 | <0.01 | 519 | 0% | +$0 | <0.0001 | |
| Advisor Group Holdings Inc | $3,201.00 | <0.01 | 671 | -44.13% | -$2,528.36 | <0.0001 | |
| Bank of America | $10.00 | <0.01 | 2 | -86.67% | -$65.00 | <0.0001 | |
| Lindbrook Capital LLC | $29.00 | <0.01 | 6 | 0% | +$0 | <0.0001 | |
| Parallel Advisors, LLC | $5.00 | <0.01 | 1 | 0% | +$0 | <0.0001 | |
| AllSquare Wealth Management, LLC | $5.00 | <0.01 | 1 | 0% | +$0 | <0.0001 | |
| Newbridge Financial Services Group Inc | $5.00 | <0.01 | 1 | 0% | +$0 | <0.0001 | |
| Allworth Financial Lp | $477.00 | <0.01 | 100 | 0% | +$0 | <0.0001 |